Product Catalog

IpamorelinSpecifications & Batch COA

Selective GH secretagogue with minimal cortisol and prolactin side effects. Ideal for anti-aging and recovery protocols.

KERUIHK-0203Ipamorelin product vial
Lyophilized PowderProduct image
Growth & Hormone

Ipamorelin

ResearchKERUIHK-0203

Selective GH secretagogue with minimal cortisol and prolactin side effects. Ideal for anti-aging and recovery protocols.

Product Specifications

CAS Number
170851-70-4
Catalog Purity
≥99.49%
Form
Lyophilized Powder
Catalog Grade
Research
View batch documentation

Product Details

Ipamorelin specifications

Use the product name, catalog reference and available specifications below when discussing your requirements with our team.

Product
Ipamorelin
Catalog reference
KERUIHK-0203
CAS number
170851-70-4
Category
Growth & Hormone
Physical form
Lyophilized Powder

Latest reported batch: Ipamorelin

Batch PB-2026-IPA-1204 · Oct 13, 2026

Reported appearance
White powder
Reported molecular weight / identity
711.81 Da
Analytical method
RP-HPLC / ESI-MS

Reported analytical results

HPLC Purity
99.35%Report specification: ≥99.0%
Molecular Weight (MS)
711.81 DaReport specification: 711.85 ± 0.3 Da
Amino Acid Analysis
ConformsReport specification: Conforms to sequence
Appearance
White powderReport specification: White to off-white powder
Show 4 more test results
Solubility
Soluble in waterReport specification: Soluble in water (≥5 mg/mL)
Water Content (KF)
4.45%Report specification: ≤ 8.0%
Residual Solvents
< ICH Q3C limitsReport specification: ICH Q3C Class 2
Sterility (USP <71>)
No growth observedReport specification: No evidence of microbial growth
Source COA: PB-2026-IPA-1204-R20261013
Explore this category

Batch Documentation

Certificates of Analysis

Open a batch below to view its full report in our COA library, including available analytical attachments and PDF download.

PB-2026-IPA-1204Report product: IpamorelinOct 13, 2026 · Reported purity: 99.35%View this batch COA
PB-2026-IPA-1204Report product: IpamorelinSep 02, 2026 · Reported purity: 99.3%View this batch COA
PB-2026-IPA-0447Report product: IpamorelinJun 29, 2026 · Reported purity: 99.1%View this batch COA
Show 3 earlier reports
PB-2026-IPA-0356Report product: IpamorelinApr 7, 2026 · Reported purity: 99.3%View this batch COA
PB-2025-IPA-0298Report product: IpamorelinSep 25, 2025 · Reported purity: 99.2%View this batch COA
PB-2025-IPA-0187Report product: IpamorelinMay 18, 2025 · Reported purity: 99.4%View this batch COA

Product Inquiry

Request a Ipamorelin quotation

We synthesize any sequence at any scale — from milligram research quantities to multi-kilogram commercial batches. OEM, private label, and GMP manufacturing available. Response within 24 hours.

Discuss your requirements
Back to all products